Landmark approvals in idiopathic pulmonary fibrosis.
Mark
M
Ratner
D017277:Drug Approval; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy* / Q000473:pathology; D007211:Indoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D007211:Indoles; D011728:Pyridones; C093844:pirfenidone; C530716:nintedanib